North America Membrane Chromatography Market

North America Membrane Chromatography Market Size (2022 to 2027)

The membrane chromatography market in North America is predicted to expand at a CAGR of 16.86% and be worth USD 120.17 million by 2027.

Increasing biopharmaceutical research and development activities and the benefits of membrane chromatography over the conventional chromatography method drive the Membrane chromatography market growth in North America. 

Depending on the separating materials, certain membranes have higher pore diameters. As a result, they have high binding efficacy, a rapid flow rate, and improved scalability.

In addition, the increasing regulatory scrutiny on the cleaning validation of downstream purification processes and a significant increase in research and development activities are expected to fuel the market growth. 

Chromatography is a scientific technique that separates the physical and chemical properties of various substances. Membrane chromatography utilizes microfiltration pore membranes with functional ligands or antigens linked to the inner pore surface throughout the membrane to generate highly selective separations through binding interactions.

Membrane chromatography is a well-established bioprocessing technology that is widely utilized in the capture of big particles such as viruses and viral vectors and polishing processes to remove DNA, host cell protein impurities (HCP), and virus. In addition, the growing demand for biopharmaceuticals and increasing regulatory focus on the cleaning validation of downstream purification processes are driving the growth of the market.

On the other hand, the technological advancements in biological products in the industry are projected to propel market growth. 

Several research initiatives are ongoing, which are likely to provide manufacturers with a competitive advantage in producing new and novel membrane chromatography products, resulting in many potential developments in the membrane chromatography market.

Further, new product launches, strategies implemented by the key market players such as collaborations, mergers, and acquisitions are more likely to expand the regional market growth. 

Moreover, the major biopharmaceutical companies are investing in research and development activities which are expected to provide lucrative growth opportunities for the market players.

However, the limited use of membrane chromatography in large-scale manufacturing is estimated to limit the market growth. Also, the technical limitations associated with chromatography hinder market growth. 

This research report on the North America membrane chromatography market has been segmented and sub-segmented into the following categories:

By Product:

• Affinity Membrane Chromatography
• Hydrophobic Interaction Membrane Chromatography (HIMC)
• Ion Exchange Membrane Chromatography

By Application:

• Chemical
• Sewage Treatment

By End-User:

• Pharmaceutical and Biopharmaceutical Companies
• CROs
• Academic and Research Institutes

By Country:

• United States,
• Canada
• Rest of North America

North America held the largest share of the membrane chromatography market, and it is projected to witness a significant share during the forecast period. The market growth is fuelled by the presence of well-established biopharmaceutical industries and the implementation of key market strategies. Furthermore, because pharmaceutical research necessitates membrane chromatography, there is a significant demand for these technologies and techniques in North America. This substantial proportion can be due to expanding biopharmaceutical demand and rising R&D spending by North American biopharmaceutical companies. In addition, the Favourable reimbursement policies and presence of key market players are further expanding the regional market growth. 

The US accounted for the majority share of the market owing to technological advancements in the healthcare sector, increasing demand for biopharmaceuticals, and high healthcare spending. Moreover, many of the world's pharmaceutical companies have their headquarters and research centers in the United States, likely to provide significant growth opportunities. 

Canada is projected to witness a considerable share in the market growth. The factors such as increasing research and development activities, supportive government policies, and key local players are fuelling the market growth. 

KEY MARKET PLAYERS:

Sartorius AG, Danaher Corporation, Merck Millipore, Thermo Fisher Scientific, 3M Company, GE Healthcare, Asahi Kasei Corporation, Cole-Parmer Instrument Company, LLC, GL Sciences Inc., Regis Technologies, Inc. and Restek Corporation are some of the leading companies in the European membrane chromatography market.